TQ416
TQ416 is a non-competitive inhibitor of paraoxonase 2 (PON2) with an IC50 of 0.775 μM for PON2. TQ416 inhibits PON2 lactonase activity, blocking PON2-dependent 3OC12HSL hydrolysis and intracellular acidification, thereby modulating mitochondrial function, Ca2+, apoptosis, and cell cycle-related responses. TQ416 is useful for research on PON2 biology and bacterial quorum sensing-related host responses.
For research use only. We do not sell to patients.
- CAS No.: 950388-70-2
- Formula: C21H21N3OS
- Molecular Weight:363.48
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
PON2 0.775 μM (IC50) |
In Vitro
TQ416 (compound 1) binds to recombinant human PON2 with Kd1 and Kd2 values of 0.042 μM and 5.70 μM, respectively[1].
TQ416 inhibits the 3OC12HSL lactonase activity of recombinant human PON2 with an IC50 of 0.775 μM[1].
TQ416 (0.25-1.25 μM) progressively decreases the Vmax of recombinant PON2 with increasing concentration while KM remains essentially unchanged, exhibiting non-competitive inhibition characteristics[1].
TQ416 (1 μM; 4 h; 100 μM C12-HSL) reduces the C12-HSL-related relative intracellular Ca2+ fluorescence intensity from 128.0254% to 110.1271% in LS174T cells[2].
TQ416 (1 μM; 4 h; 100 μM C12-HSL) restores the relative mRNA expression levels of CCND1 and CCND2 from 0.4262 and 0.4706 to 0.7975 and 1.0444, respectively, in LS174T cells[2].
TQ416 inhibits 3OC12 hydrolysis activity in purified recombinant PON2 and HEK PON2 cell lysates in a concentration-dependent manner[3].
TQ416 (0.5-1 μM; 50 μM 3OC12) inhibits PON2-dependent 3OC12-induced cytoplasmic acidification in EA.hy PON2 cells[3].
TQ416 (1 μM; 2 h or 4 h) increases endogenous PON2 protein levels by approximately 20% and 40-50%, respectively, in HeLa cells[1].
TQ416 (1 μM; 2 h or 4 h) reduces normalized PON2 lactonase activity to approximately 40% and 35% of control, respectively, in HeLa cells[1].
TQ416 (1 μM; 2 h or 4 h) increases endogenous PON2 protein levels by approximately 15% and 45-60% in A549 cells, respectively[1].
TQ416 (1 μM; 2 h or 4 h) reduces normalized PON2 lactonase activity to 45-50% of the control in A549 cells[1].
TQ416 (1 μM; 4 h; 100 μM C12-HSL (HY-118697)) reduces C12-HSL-related mitochondrial respiratory chain complex IV activity from 115.4910 to 48.6712 nmol/min/μg protein in LS174T cells[2].
TQ416 (1 μM; 4 h; 100 μM C12-HSL) reduces C12-HSL-related mitochondrial respiratory chain complex V activity from 17.3764 to 9.7317 nmol/min/μg protein in LS174T cells[2].
TQ416 (1 μM; 4 h; 100 μM C12-HSL) reduces C12-HSL-associated intracellular ATP levels from 1.2380 to 1.0006 nmol/mg protein in LS174T cells[2].
TQ416 (1 μM; 4 h; 100 μM C12-HSL) restores the relative fluorescence intensity of C12-HSL-associated mitochondrial activity from 49.0322% to 102.3002% in LS174T cells[2].
TQ416 (1 μM; 4 h; 100 μM C12-HSL) decreases the relative mRNA expression levels of caspase-6, caspase-8, caspase-9, and caspase-10 from 1.6745, 2.0977, 3.3133, and 2.9879 to 0.9539, 1.0949, 1.3402, and 1.3909, respectively, in LS174T cells[2].
TQ416 (1 μM; 4 h; 100 μM C12-HSL) restores the G0/G1 phase proportion of LS174T cells from 78.1133% to 67.5267% and restores the S+G2/M phase proportion from 21.8867% to 32.4733%[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:HeLa and A549 human cell lines
-
Concentration:1 μM
-
Incubation Time:2 h; 4 h
-
Result:Induced a time-dependent increase in endogenous PON2 protein expression in both cell lines.
In HeLa cells, increased PON2 levels by approximately 20% at 2 h and 40-50% at 4 h relative to untreated controls.
In A549 cells, increased PON2 levels by approximately 15% at 2 h and 45-60% at 4 h relative to untreated controls.
Substantially inhibited lactonase activity despite the increase in protein abundance.
Reduced residual lactonase activity in HeLa cells to ~40% at 2 h and ~35% at 4 h compared with controls.
Reduced residual lactonase activity in A549 cells to 45-50% compared with controls.
-
Cell Line:human colonic goblet LS174T cells
-
Concentration:1 μM (co-treated with 100 μM C12-HSL)
-
Incubation Time:4 h
-
Result:Reduced caspase-6 mRNA relative abundance from 1.6745 to 0.9539.
Reduced caspase-8 from 2.0977 to 1.0949.
Reduced caspase-9 from 3.3133 to 1.3402.
Reduced caspase-10 from 2.9879 to 1.3909.
Increased CCND1 mRNA relative abundance from 0.4262 to 0.7975.
Increased CCND2 mRNA relative abundance from 0.4706 to 1.0444.
-
Cell Line:human colonic goblet LS174T cells
-
Concentration:1 μM (co-treated with 100 μM C12-HSL)
-
Incubation Time:4 h
-
Result:Reduced the G0/G1-phase proportion from 78.1133% to 67.5267%.
Increased the S+G2/M-phase proportion from 21.8867% to 32.4733%.
Chemical Information
-
CAS No. 950388-70-2
-
Molecular Weight 363.48
-
Formula C21H21N3OS
-
SMILES
CC(C=C1)=CC=C1OCCSC2=NN=C3C=C(C)C4=C(N32)C(C)=CC=C4
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Mitochondrial membrane-potential fluorescent assay
Mitochondrial membrane potential fluorescent assays estimate ΔΨm in living cells using lipophilic cationic dyes such as TMRM, TMRE, rhodamine 123, and JC-1, which accumulate in mitochondria according to membrane polarization; loss of signal after FCCP or CCCP treatment is interpreted as mitochondrial depolarization. TMRM/TMRE and rhodamine 123 are commonly used for semi-quantitative live-cell microscopy or flow cytometry, while JC-1 can report a shift from red aggregate fluorescence to green monomer fluorescence during depolarization; interpretation requires controls because dye concentration, quenching mode, cell type, dye efflux, and mitochondrial mass can affect fluorescence independently of ΔΨm.
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Flow cytometric DNA-content cell-cycle staining
Flow cytometric DNA-content cell-cycle staining measures the fluorescence intensity of DNA-bound fluorochromes in single cells or nuclei to estimate DNA content distributions, allowing assignment of populations to G0/G1, S, and G2/M phases by DNA histogram deconvolution. Propidium iodide (PI) intercalates into DNA, and PI fluorescence is proportional to cellular DNA content when staining is performed under conditions that make DNA accessible and minimize non-DNA signal. Cells with G2/M DNA content are expected to show approximately twice the fluorescence intensity of G0/G1 cells, while S-phase cells occupy intermediate fluorescence values. PI-based DNA-content analysis can also detect cells with fractional DNA content, often reported as sub-G1, when DNA fragmentation and extraction during staining reduce retained DNA signal in apoptotic cells. DAPI is an alternative DNA fluorochrome for univariate DNA-content analysis, while bivariate approaches combining DNA content with proliferation
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
BrdU Incorporation Assay
Bromodeoxyuridine (BrdU) incorporation assay is based on the principle that BrdU, a thymidine analog, is incorporated into newly synthesized DNA during the S phase of the cell cycle, thereby serving as a marker of DNA replication and cellular proliferation. Incorporated BrdU can be detected using anti-BrdU antibodies following DNA denaturation, enabling visualization or quantification of proliferating cells through immunochemical detection methods such as immunofluorescence or immunohistochemistry.
-
Mitochondrial membrane-potential and mitochondrial mass staining
Mitochondrial membrane potential staining measures the electrochemical polarization across the mitochondrial inner membrane in live cells using lipophilic cationic fluorescent probes; early rhodamine-based work showed that selective mitochondrial dye accumulation is lost when the mitochondrial transmembrane potential is dissipated. JC-1 reports mitochondrial polarization by shifting from green monomer fluorescence to red J-aggregate fluorescence as dye concentration increases within energized mitochondria; therefore, the red/green fluorescence ratio is used as a relative readout of mitochondrial membrane potential. TMRE or TMRM staining provides a single-channel relative readout because these cationic rhodamine esters accumulate in polarized mitochondria, and lower fluorescence indicates reduced mitochondrial polarization when acquisition and dye-loading conditions are controlled. Mitochondrial mass staining is commonly performed with MitoTracker Green FM or related MitoTracker dyes as
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Protocol for Cell Cycle
Cell-cycle analysis by flow cytometry measures DNA content in single cells to estimate the fraction of cells in G0/G1, S, and G2/M phases. Propidium iodide intercalates into DNA, and after RNA removal with RNase, fluorescence intensity reflects cellular DNA content: 2N cells are assigned to G0/G1, cells between 2N and 4N to S phase, and 4N cells to G2/M. DNA-content analysis alone cannot reliably separate G0 from G1 or G2 from M. Ki-67 can distinguish quiescent G0 cells from cycling cells, EdU or BrdU incorporation marks active DNA synthesis in S phase, and phospho-histone H3 staining identifies mitotic cells within the 4N population.
-
Ca2+ Staining Technique
Ca2+ staining is an experimental technique that utilizes specific fluorescent probes (such as Fluo-4 AM, Fura-2, etc.) to qualitatively or quantitatively detect dynamic changes in intracellular Ca2+ concentrations; this is achieved by monitoring the changes in fluorescent signals generated when these probes bind to free intracellular calcium ions. The underlying principle relies primarily on the presence of chelating groups within the probe's molecular structure that possess high affinity for calcium ions.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)